Chemical Compound

Neomycin F

CAS Registry Number 51795-47-2
Back to search Request a Quote
Neomycin F chemical structure
Primary Record

Neomycin F

In stock
5,148 g
Purity
99.8 %
CAS
51795-47-2

Compound Identifiers & Properties

CAS
51795-47-2
PubChem CID
3040200
SMILES
C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CN)O)O)N)O)O)N
Canonical SMILES
NC[C@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O

Names & Synonyms

  • Neomycin F
  • Paromomycin II
  • Aminosidine II
  • Zygomycin A2
  • Aminosidin II
  • paromomycin
  • Aminocidin II
  • M8T6ND38GK
  • Neomycin EP Impurity F
  • AC1MI8JT
  • RefChem:165309
  • UNII-M8T6ND38GK
  • Neomycin Sulfate EP Impurity F
  • DTXSID80199724
  • orb3024755
  • 51795-47-2
  • SCHEMBL29430305
  • CHEBI:81287
  • DTXCID40122215
  • BBF-02368
  • C23-H45-N5-O14
  • CID3040200
  • J87.130C
  • LS-146933
  • NEOMYCIN SULFATE IMPURITY F [EP IMPURITY]
  • C17712
  • NEOMYCIN SULFATE IMPURITY F (EP IMPURITY)
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(2R,3S,4R,5S)-5-[(1R,2R,3S,5R,6S)-3,5-diamino-2-[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-hydroxycyclohexyl]oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxyoxane-3,4-diol
  • Q27155227
  • Streptamine, O-2-amino-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-
  • Framycetin Sulfate EP Impurity F; Neomycin Sulfate EP Impurity F
  • 4-O-(2-AMINO-2-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL)-2-DEOXY-5-O-(3-O-(2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL)-.BETA.-D-RIBOFURANOSYL)-D-STREPTAMINE
  • D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->3)-O-.BETA.-D-RIBOFURANOSYL-(1->5)-O-(2-AMINO-2-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-
  • D-STREPTAMINE, O-2-AMINO-2-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->3)-.BETA.-D-RIBOFURANOSYL-(1->5))-2-DEOXY-
  • PAROMOMYCIN I, AMMINOSIDIN, CATENULIN, CRESTOMYCIN, MONOMYCIN A, NEOMYCIN E
  • (1R,2R,3S,4R,6S)-4,6-Diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2-amino-2-deoxy-alpha-D-glucopyranoside
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-((2R,3S,4R,5S)-5-((1R,2R,3S,5R,6S)-3,5-diamino-2-((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-6-hydroxycyclohexyl)oxy-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl)oxyoxane-3,4-diol
  • (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol
  • 4-O-(2-Amino-2-deoxy--D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy--D-glucopyranosyl)--D-ribofuranosyl]-2-deoxy-D-streptamine
  • 4-O-(2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL)-2-DEOXY-5-O-(3-O-(2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL)-BETA-D-RIBOFURANOSYL)-D-STREPTAMINE
  • 4-O-(2-Amino-2-deoxy-alpha-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-ribofuranosyl]-2-deoxy-D-streptamine
  • D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->3)-O-BETA-D-RIBOFURANOSYL-(1->5)-O-(2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-
  • D-STREPTAMINE, O-2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->4)-O-(O-2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSYL-(1->3)-BETA-D-RIBOFURANOSYL-(1->5))-2-DEOXY-
  • Paromomycin II; (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-(((2R,3S,4R,5S)-5-(((1R,2R,3S,5R,6S)-3,5-diamino-2-(((2S,3R,4R,5S,6R)-3-amino-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-hydroxycyclohexyl)oxy)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)oxy)tetrahydro-2H-pyran-3,4-diol